.75 AMA PRA Category 1 Credit(s)™,
.75 AOA Category 1-A Credit(s)
- Average Rating:
Robert N. Cooley, DO
- Short Description:
- This presentation will focus on key safety considerations for pain, depression, and anxiety medication management in the primary care setting. The pain management section will provide information about buprenorphine and cannabis and review basic safety guidelines. The depression segment will focus on diagnostic accuracy and suicide risk and explain the use of recommended atypical antipsychotics. The anxiety section will focus on the detriments of long-term treatment with benzodiazepines and recommend safer alternatives.